Scholars Central

EditorialPublished 30 Sep 2024

Biopharmaceutics of CRISPR-based Therapies: Evaluating Delivery Mechanisms and Efficacy

Authors: Emmanuel Ekott

Department of Pharmaceutics and Pharmaceutical Technology, University of Uyo, Nigeria

Clinical Pharmacology & Biopharmaceutics

Volume 13 · Issue 9 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

CRISPR-based therapies have revolutionized the field of gene editing, offering unprecedented potential for treating genetic disorders and various diseases. However, the successful application of these therapies is heavily dependent on the effectiveness of delivery mechanisms and the overall biopharmaceutics of CRISPR constructs. This article provides a comprehensive review of the current strategies for delivering CRISPR-based therapeutics, including viral vectors, nanoparticles, and other innovative methods. We analyze the efficacy of these delivery systems in preclinical and clinical settings, discuss their advantages and limitations, and explore recent advancements aimed at improving the precision and efficiency of CRISPR gene editing. The review also addresses the pharmacokinetics and pharmacodynamics of CRISPR therapies, offering insights into how these factors influence therapeutic outcomes. By evaluating these aspects, we aim to provide a holistic understanding of the biopharmaceutics of CRISPR-based therapies and highlight future directions for enhancing their clinical application.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Emmanuel Ekott”